Stifel Financial’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,247
Closed -$368K 3395
2023
Q4
$368K Buy
19,247
+3,551
+23% +$68K ﹤0.01% 2728
2023
Q3
$252K Buy
15,696
+1,592
+11% +$25.5K ﹤0.01% 2878
2023
Q2
$327K Sell
14,104
-444
-3% -$10.3K ﹤0.01% 2771
2023
Q1
$338K Buy
14,548
+1,992
+16% +$46.3K ﹤0.01% 2732
2022
Q4
$182K Sell
12,556
-4,998
-28% -$72.5K ﹤0.01% 2999
2022
Q3
$335K Buy
17,554
+897
+5% +$17.1K ﹤0.01% 2659
2022
Q2
$303K Sell
16,657
-1,188
-7% -$21.6K ﹤0.01% 2744
2022
Q1
$450K Sell
17,845
-976
-5% -$24.6K ﹤0.01% 2632
2021
Q4
$519K Sell
18,821
-891
-5% -$24.6K ﹤0.01% 2568
2021
Q3
$637K Sell
19,712
-93
-0.5% -$3.01K ﹤0.01% 2437
2021
Q2
$606K Sell
19,805
-2,921
-13% -$89.4K ﹤0.01% 2468
2021
Q1
$691K Buy
22,726
+6,911
+44% +$210K ﹤0.01% 2263
2020
Q4
$313K Buy
15,815
+1,172
+8% +$23.2K ﹤0.01% 2575
2020
Q3
$190K Sell
14,643
-12,104
-45% -$157K ﹤0.01% 2633
2020
Q2
$303K Buy
26,747
+3,424
+15% +$38.8K ﹤0.01% 2356
2020
Q1
$332K Sell
23,323
-57,357
-71% -$816K ﹤0.01% 2112
2019
Q4
$2.2M Buy
80,680
+55,054
+215% +$1.5M ﹤0.01% 1275
2019
Q3
$733K Sell
25,626
-50,801
-66% -$1.45M ﹤0.01% 1946
2019
Q2
$2.12M Buy
76,427
+61,276
+404% +$1.7M 0.01% 1291
2019
Q1
$504K Sell
15,151
-58,519
-79% -$1.95M ﹤0.01% 2058
2018
Q4
$2.14M Buy
73,670
+13,285
+22% +$386K 0.01% 1117
2018
Q3
$2.78M Buy
60,385
+3,317
+6% +$153K 0.01% 1095
2018
Q2
$2.13M Buy
57,068
+2,925
+5% +$109K 0.01% 1175
2018
Q1
$1.6M Buy
54,143
+635
+1% +$18.8K 0.01% 1284
2017
Q4
$1.84M Sell
53,508
-900
-2% -$30.9K 0.01% 1190
2017
Q3
$1.97M Buy
54,408
+1,900
+4% +$68.7K 0.01% 1134
2017
Q2
$1.36M Buy
+52,508
New +$1.36M 0.01% 1295
2016
Q1
Sell
-10,718
Closed -$463K 2332
2015
Q4
$463K Buy
+10,718
New +$463K ﹤0.01% 1706
2014
Q4
Sell
-7,053
Closed -$272K 2350
2014
Q3
$272K Buy
+7,053
New +$272K ﹤0.01% 1844
2014
Q2
Sell
-10,184
Closed -$348K 2198
2014
Q1
$348K Buy
+10,184
New +$348K ﹤0.01% 1631